SCHEMBL8887751

SCHEMBL8887751

O=C(O)c1ccccc1S(=O)(=O)NCCCCBr

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 6/20 0.74
CA9 Q16790 6/20 0.74
LPAR2 Q9HBW0 3/20 0.56
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
MMP1 P03956 1/20 0.55
MMP2 P08253 1/20 0.55
MMP9 P14780 1/20 0.55
MMP8 P22894 1/20 0.55
MMP13 P45452 1/20 0.55
F2 P00734 1/20 0.48
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
ALDH1A1 P00352 4/20 0.47
FABP4 P15090 1/20 0.47
RECQL P46063 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 2/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8884828 0.99 CA12 (0.72) CA12CA9LPAR2CA1CA2
SCHEMBL8885028 0.95 CA12 (0.74) CA12CA9LPAR2CA1CA2
SCHEMBL3336990 0.85 CA12 (1.00) CA12CA9LPAR2CA1CA2
SCHEMBL10766816 0.84 CA12 (0.97) CA12CA9LPAR2CA1CA2
SCHEMBL9490703 0.84 CA12 (0.97) CA12CA9LPAR2CA1CA2
SCHEMBL9490269 0.84 CA12 (0.97) CA12CA9LPAR2CA1CA2
SCHEMBL1924309 0.80 CA12 (0.72) CA12CA9LPAR2CA1CA2
SCHEMBL13320282 0.78 CA12 (0.79) CA12CA9LPAR2CA1CA2
SCHEMBL26212219 0.77 CA12 (0.71) CA12CA9LPAR2CA1CA2
SCHEMBL1923940 0.77 CA12 (0.71) CA12CA9LPAR2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997046525-A1 5-ALKOXY-TRYPTAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS 5-HT1D RECEPTOR AGONISTS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1997-12-11 WO disclosed
US-5654431-A EXHIBIT SELECTIVITY TOWARDS 5-HYDROXYTRYPTAMINE RECEPTORS OF BRAIN CELLS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1997-08-05 US disclosed